4AB:FRA
AbbVie Common Stock
262,80 €
arrow_upward
+1,04%(+2,70) 1 d.
20. nov., 22:00:00 GMT+1 · EUR
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: 4AB…
Atvērt
259,20 €
Augsta
262,80 €
Zema
258,60 €
Tirgus kapitalizācija
505,89 mljrd.
Vid. apjoms
101,00
Apjoms
75,00
Augstākā 52 ned.
272,30 €
Zemākā 52 ned.
167,55 €
Darbinieku skaits
57 tūkst.
Atvērt
259,20 €
Augsta
262,80 €
Zema
258,60 €
Tirgus kapitalizācija
505,89 mljrd.
Vid. apjoms
101,00
Apjoms
75,00
Augstākā 52 ned.
272,30 €
Zemākā 52 ned.
167,55 €
Darbinieku skaits
57 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
The Motley Fool
·
pirms 7 stundām
AbbVie vs. Eli Lilly: Which Healthcare Stock Is a Better Buy for 2027?
ad-hoc-news.de
·
pirms 8 stundām
AbbVie stock trades 2.05% above Xetra close
Euronext Markets: Real-time Stock Market Data | live
·
pirms 1 dienas
AbbVie expands bispecific cancer med push with up to $2.5 billion deal with Germany's Disco
Investing.com
·
pirms 2 dienām
Abbvie stock price target raised to $349 by Piper Sandler on growth
Profils
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
Par “AbbVie Common Stock”
ĢenerāldirektorsRobert A. Michael
Darbinieki57 tūkst.
Dibināšanas datums2012. gada 10. apr.
Galvenais birojsNorth Chicago, Ilinoisa, Amerikas Savienotās Valstis
SektorsHealth Care
Nozare-
Tīmekļa vietneabbvie.com